Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation

January 24, 2023 Business Services

London, 24th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the …
News
Press release

UK seeing exodus of R&D activity, research reveals

January 24, 2023 Business Services

London, 24 January 2023: The UK is experiencing a crisis where firms are moving R&D activity abroad, according to research …
News
Press release

Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence

January 24, 2023 Business Services

London, UK and Antwerp, Belgium. 24th January 2023 – Amber Therapeutics (‘Amber’ or the ‘Company’), a University of Oxford spinout …
News
Press release

2022 Novo Holdings Seed Investments team Review/Business Update

January 24, 2023 Business Services

Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo Holdings, today …
News
Press release

Global Company Foot Science International Choose Onyx Health

January 24, 2023 Business Services

Leading orthotics company Foot Science International has joined forces with creative agency Onyx Health to launch a new medical education …
News
Press release

Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg

January 24, 2023 Business Services

Brussels and Düsseldorf – January 24, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …
News
Press release

Modus Therapeutics submits patent application for sevuparin in kidney disease

January 23, 2023 Business Services

STOCKHOLM, SWEDEN – 23 January 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …
News
Press release

Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT)

January 23, 2023 Business Services

Dublin, Ireland – January 23, 2023 – Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound …
News
Press release

NICE recommends AMVUTTRA®▼ (vutrisiran) as treatment for a hereditary form of amyloidosis in draft guidance

January 19, 2023 Business Services

MAIDENHEAD, UK, 19th January 2023 – Alnylam UK Limited, the leading RNA interference (RNAi) therapeutics company, today welcomed a draft …
News
Press release

Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium

January 19, 2023 Business Services

PARIS, France, and PRINCETON, N.J., January 19, 2023 – Servier and Taiho Oncology, Inc., today announced the release of data …
News
Press release

NeoPhore completes extension to Series B financing to further advance discovery pipeline

January 19, 2023 Business Services

Cambridge, UK, 19 January 2023 – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the completion of its £21.5m …
News
Press release

PFIZER EXPANDS ‘AN ACCORD FOR A HEALTHIER WORLD’ PRODUCT OFFERING TO INCLUDE FULL PORTFOLIO FOR GREATER BENEFIT TO 1.2 BILLION PEOPLE IN 45 LOWER-INCOME COUNTRIES

January 18, 2023 Business Services

DAVOS, Switzerland, January 17, 2023 – Pfizer Inc.
News
Press release

Green Bioactives appoints experienced biotech leaders Chris Meaney and Andy Hall-Ponselé to expand senior management team

January 17, 2023 Business Services

Edinburgh, Scotland, 17 January 2023 – Green Bioactives Limited (‘GBL’), a world-leader in the discovery, development and sustainable production of …
Appointment

AstraZeneca UK, Qure.ai and Greater Manchester Cancer Alliance Join Forces to Battle Lung Cancer Waiting Times Using Artificial Intelligence (AI) Technology

January 17, 2023 Business Services

London, UK, 13 January 2023 – An initiative to improve earlier diagnosis of lung cancer has been launched by AstraZeneca UK, …
News
Press release

The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations

January 16, 2023 Business Services

16 January 2023, Feltham (Merck) – Today Merck, a leading science and technology company, announced that following a resubmission to …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025